Quarterly report pursuant to Section 13 or 15(d)

Research and Development Agreements - Schedule of Deferred Revenue, Other Liabilities for Co-share Payments and Accounts Receivable Balances from the Research and Development Agreements (Detail)

v3.20.2
Research and Development Agreements - Schedule of Deferred Revenue, Other Liabilities for Co-share Payments and Accounts Receivable Balances from the Research and Development Agreements (Detail) - USD ($)
$ in Thousands
Sep. 30, 2020
Dec. 31, 2019
Assets    
Accounts receivable $ 301 $ 408
Liabilities    
Other current liabilities 2,041 2,501
Other liabilities 1,458 1,366
Total liabilities 84,936 71,174
Takeda    
Assets    
Accounts receivable 301 408
Liabilities    
Other current liabilities 5,498 0
Deferred revenue, current 4,566 8,780
Deferred revenue, non-current 935 441
Other liabilities 6,711 0
Total liabilities $ 17,710 $ 9,221